(Q40374373)

English

Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells

scientific article published on January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells (English)

1 reference

Europe PubMed Central

19 September 2017

cholecalciferol

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1

object named as

Erik J Tokar

1 reference

Europe PubMed Central

19 September 2017

author name string

Mukta M Webber

2

1 reference

Europe PubMed Central

19 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2005

1 reference

Europe PubMed Central

19 September 2017

Clinical & Experimental Metastasis

1 reference

Europe PubMed Central

19 September 2017

22

1 reference

Europe PubMed Central

19 September 2017

3

1 reference

Europe PubMed Central

19 September 2017

275-284

1 reference

Europe PubMed Central

19 September 2017

https://scigraph.springernature.com/pub.10.1007/s10585-005-8393-z

0 references

Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model

1 reference

https://api.crossref.org/works/10.1007%2FS10585-005-8393-Z

21 January 2018

Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity: a model for cancer chemoprevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of cancer in negroes in Washington, D.C. and selected African cities

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma vitamin D metabolites and risk of colorectal cancer in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of nuclear retinoid receptors in normal and malignant prostates

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1α,24‐dihydroxyvitamin D2

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression patterns of vitamin D receptor in human prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16158255

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10585-005-8393-Z

1 reference

Europe PubMed Central

19 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40374373&oldid=1966877181"